Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for treating post-traumatic brain syndrome

A technology for the sequelae and composition of traumatic brain injury, which can be used in drug combinations, pharmaceutical formulations, plant raw materials, etc., and can solve the problems of lack of specific treatment methods, lack of drugs with definite curative effects, etc.

Inactive Publication Date: 2014-05-28
李树志
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For the treatment of sequelae of traumatic brain injury, there is currently a lack of drugs with definite curative effects, and there is also a lack of specific treatment methods in Western medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0051] Embodiment of the invention

[0052] Prepare the medicine according to the dosage of the following medicines: Chuanxiong 4kg, Pittosporum 3kg, Ginger 3kg, Achyranthes bidentata 3kg, Wang Buliuxing 3kg, Jiguxiang 3kg, Rose 3kg, Geshanxiang 3kg, Notopterygium 4kg, Duhuo 3kg, Heather 3kg, Redwood 3kg, Shichangpu 4kg, Chrysanthemum 3kg, Uncaria 2kg, Bupleurum 2kg, Amber 1kg, Sagittarius 2kg, Patrinia 2kg, Plantago 2kg, Artemisia annua 4kg, Adenophora 2kg, Digus Skin 3kg, wolfberry 4kg, dodder 3kg, astragalus 4kg, red ginseng 4kg, angelica 4kg, panax notoginseng 3kg; wash and dry all the medicinal materials in the formula, grind them into fine powder through No. 6 medicine sieve, add appropriate amount of honey to make pills , Store away from light for later use.

[0053] The effect of the pharmaceutical composition of the present invention for treating sequelae of traumatic brain injury will be further illustrated through clinical treatment observation cases.

[0054] 1. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating post-traumatic brain syndrome. The pharmaceutical composition is characterized by being prepared from the following materials: szechuan lovage rhizome, bark of oriental variegated coralbean, rhizome of Japanese galangal, radix achyranthis bidentatae, cowherb seed, thickleaf croton root, flos rosae rugosae, root of lemonfragrant ostericum, rhizome et radix notopterygii, radix angelicae pubescentis, photinia serrulata, seed of calyx-shaped carrierea, grassleaf sweelflag rhizome, flos chrysanthemi, uncariae ramulus cum uncis, radix bupleuri, succvinum amber, sargentgloryvine stem, dahurian patrinia herb, plantain seed, sweet wormwood herb, root of straight ladybel, cortex lycii, fructus lycii, semen cuscutae, radix astragali, radix ginseng rubra, radix angelicae sinensis and radix notoginseng. Brain collateral injure, a post-traumatic brain syndrome, causes blood stasis and weakness, and thus endogenous wind and exogenous wind seize the opportunity to get in; pathogenic wind blocks collaterals to cause pathogenic factors to block meridians, and thus causes exuberance of deficiency-heat; qi and blood are unsmooth to cause blood stasis, depression causes heat, and the pathogenesis is blood stasis, qi stagnation, blood stasis on head, qi-blood deficiency, and deficiency of liver and kidney. According to the invention, removing blood stasis and wind, promoting qi circulation, removing obstruction in collaterals, inducing resuscitation, promoting blood circulation, enriching blood and qi, soothing nerves, tonifying deficiency, nourishing liver and kidney, and tonifying brains are taken as rules of treatment so as to achieve the purpose of treating post-traumatic brain syndrome.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating sequelae of traumatic brain injury. Background technique [0002] Sequelae of traumatic brain injury refers to a group of autonomic nervous dysfunction or psychiatric symptoms that persist for more than three months after the recovery period of traumatic brain injury patients. Disorders, etc., clinical symptoms include varying degrees of loss of consciousness, headache, nervousness, irritability, attention disturbance, memory disturbance, nausea, dizziness, insomnia, fatigue, etc. , and memory loss are the most common. The sequelae of traumatic brain injury are more common in patients with mild or moderate closed craniocerebral trauma, and the incidence rate accounts for about 20% of patients with craniocerebral injury. It brings great pain and mental pressure to patients, and affects their work and life. More patients with post-traumatic brain injury are accompanied by symptoms of an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9062A61P25/00A61K35/10
Inventor 李树志王美香
Owner 李树志
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products